Literature DB >> 7718164

Pleomorphic xanthoastrocytoma--report of four cases, with MRI scan appearances and literature review.

K G Davies1, R E Maxwell, E Seljeskog, J H Sung.   

Abstract

Pleomorphic xanthoastrocytoma (PXA) is a rare glial tumour typically occurring in young patients in the first three decades, having a superficial cortical location and with a relatively good prognosis for long-term survival. Four cases are reviewed. The magnetic resonance imaging (MRI) appearances, which in PXA have been reported only once before, are described in three cases. The fourth case was studied by computed tomography and angiography. One patient developed seizures at age 2 days and was aged 2 1/2 years at presentation. This is the youngest patient with PXA yet reported. Three of the four patients had seizures, but in one case the tumour was not the cause of the seizures. Review of the literature has revealed 47 reported cases. Mean age at presentation was 14.3 years. Epilepsy occurred in 78%. Seventeen patients were alive without recurrence at a mean of 7.9 years after diagnosis and 10 patients died at a mean of 7.4 years after diagnosis. Thirteen cases had recurrence at a mean of 6 years after surgery and in five instances the recurrence was in the form of a glioblastoma. Resections which were grossly total were less likely to develop recurrence than those which were subtotal. Complete gross resection of tumour offers the best therapeutic option in PXA.

Entities:  

Mesh:

Year:  1994        PMID: 7718164     DOI: 10.3109/02688699409101181

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  8 in total

1.  Pleomorphic xanthoastrocytoma of the cerebellopontine angle in a child.

Authors:  Senta Kurschel; Arielle Lellouch-Tubiana; Abhaya V Kulkarni; Christian Sainte-Rose
Journal:  Childs Nerv Syst       Date:  2006-09-19       Impact factor: 1.475

2.  Coexistence of pleomorphic xanthoastrocytoma with Sturge-Weber syndrome: MRI features.

Authors:  Ozgur Kilickesmez; Hatice Tuba Sanal; Aptullah Haholu; Erhan Kocamaz
Journal:  Pediatr Radiol       Date:  2005-05-10

3.  Prognostic factors and therapeutic outcomes in 22 patients with pleomorphic xanthoastrocytoma.

Authors:  Sungryong Lim; Jeong Hoon Kim; Sun A Kim; Eun Suk Park; Young Shin Ra; Chang Jin Kim
Journal:  J Korean Neurosurg Soc       Date:  2013-05-31

4.  Pleomorphic xanthoastrocytomas: immunohistochemistry, grading and clinico-pathologic correlations. An analysis of 34 cases from a single Institute.

Authors:  A Korshunov; A Golanov
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

Review 5.  The evolution of pleomorphic xanthoastrocytoma: from genesis to molecular alterations and mimics.

Authors:  Swati Mahajan; Iman Dandapath; Ajay Garg; Mehar C Sharma; Vaishali Suri; Chitra Sarkar
Journal:  Lab Invest       Date:  2022-01-14       Impact factor: 5.662

6.  Pleomorphic xanthoastrocytoma: a developmental glioneuronal tumor with prominent glioproliferative changes.

Authors:  So-Hyang Im; Chun Kee Chung; Seung-Ki Kim; Byung-Kyu Cho; Min-Kyung Kim; Je G Chi
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

Review 7.  Pleomorphic xanthoastrocytoma: a brief review.

Authors:  Nawal Shaikh; Nupur Brahmbhatt; Tim J Kruser; Kwok L Kam; Christina L Appin; Nitin Wadhwani; James Chandler; Priya Kumthekar; Rimas V Lukas
Journal:  CNS Oncol       Date:  2019-09-19

Review 8.  BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors.

Authors:  Dario Talloa; Silvia Triarico; Pierpaolo Agresti; Stefano Mastrangelo; Giorgio Attinà; Alberto Romano; Palma Maurizi; Antonio Ruggiero
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.